002603.SHE · Shijiazhuang Yiling Pharmaceutical Co., Ltd

-

Please sign in to comment on 002603.SHE

1 Comment

Admin

4 years ago

Shijiazhuang Yiling Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 25.2% below its 200 day moving average.

From a valuation standpoint, the stock is 61.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.7.

Shijiazhuang Yiling Pharmaceutical Co., Ltd's total revenue rose by 32.6% to $2B since the same quarter in the previous year.

Its net income has increased by 856.1% to $302M since the same quarter in the previous year.

Finally, its free cash flow grew by 35.5% to $-248M since the same quarter in the previous year.

Based on the above factors, Shijiazhuang Yiling Pharmaceutical Co., Ltd gets an overall score of 4/5.

Exchange	SHE
CurrencyCode	CNY
ISIN	CNE1000015S0
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

Market Cap	22B
PE Ratio	149.33
Target Price	18.11
Dividend Yield	2.1%
Beta	0.77

ABOUT

Shijiazhuang Yiling Pharmaceutical Co., Ltd

Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for respiratory health, cardiovascular disease, diabetes mellitus, oncology, urologic disease, sleep-improving, and anti-aging. The company also provides dietary supplements, health food and drinks, disinfection products, and personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.

002603.SHE · Shijiazhuang Yiling Pharmaceutical Co., Ltd

-

Shijiazhuang Yiling Pharmaceutical Co., Ltd

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Shijiazhuang Yiling Pharmaceutical Co., Ltd using a moving average strategy